Silo Pharma initiates safety study for PTSD drug SPC-15
Silo Pharma, Inc., a biopharmaceutical company focused on developing novel treatments, has commenced a critical safety study for its lead…
Silo Pharma, Inc., a biopharmaceutical company focused on developing novel treatments, has commenced a critical safety study for its lead…
Eating can be a significant challenge for individuals with Pathological Demand Avoidance (PDA), a profile within the autism spectrum characterized…
Dr. Akta Bajaj, an obstetrician-gynecologist at Ujala Cygnus Group of Hospitals, clarifies the distinction between ‘baby blues’ and postpartum depression…
Eating disorders are serious conditions characterized by abnormal eating behaviors and an intense preoccupation with body weight and shape. These…
Portugal has taken a significant step in mental health treatment by approving public funding for Spravato, the first medicine containing…
Research indicates that childhood trauma can more than double the likelihood of developing an eating disorder later in life. This…
A recent study published in Psychological Medicine examined whether brain functional connectivity and anatomical features could predict the outcomes of…
BetterLife Pharma has shared encouraging preclinical findings regarding BETR-001, a non-hallucinogenic compound aimed at treating psychiatric disorders. BETR-001 selectively activates…
Neuronetics, Inc. (NASDAQ: STIM) has established the first National TMS Therapy Awareness Day, which will be observed annually on May…
Обсессивно-компульсивным расстройством (ОКР) страдает примерно 1 из 100 взрослых людей, что приводит к навязчивым мыслям и повторяющемуся поведению, которые значительно нарушают...